| Year |
Citation |
Score |
| 2024 |
Bollack A, Collij LE, García DV, Shekari M, Altomare D, Payoux P, Dubois B, Grau-Rivera O, Boada M, Marquié M, Nordberg A, Walker Z, Scheltens P, Schöll M, Wolz R, et al. Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38574374 DOI: 10.1002/alz.13761 |
0.576 |
|
| 2024 |
Hönig M, Altomare D, Caprioglio C, Collij L, Barkhof F, Van Berckel B, Scheltens P, Farrar G, Battle MR, Theis H, Giehl K, Bischof GN, Garibotto V, Molinuevo JLL, Grau-Rivera O, ... ... Nordberg AK, et al. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease. Neurology. 102: e208053. PMID 38377442 DOI: 10.1212/WNL.0000000000208053 |
0.312 |
|
| 2023 |
Fontana IC, Kumar A, Okamura N, Nordberg A. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer's Brains. Acs Chemical Neuroscience. PMID 38133820 DOI: 10.1021/acschemneuro.3c00646 |
0.336 |
|
| 2023 |
Bader I, Bader I, Lopes Alves I, Vállez García D, Vellas B, Dubois B, Boada M, Marquié M, Altomare D, Scheltens P, Vandenberghe R, Hanseeuw B, Schöll M, Frisoni GB, Jessen F, ... Nordberg A, et al. Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study. Alzheimer's Research & Therapy. 15: 189. PMID 37919783 DOI: 10.1186/s13195-023-01332-4 |
0.634 |
|
| 2023 |
Chiotis K, Johansson C, Rodriguez-Vieitez E, Ashton NJ, Blennow K, Zetterberg H, Graff C, Nordberg A. Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP. Molecular Neurodegeneration. 18: 60. PMID 37697307 DOI: 10.1186/s13024-023-00647-y |
0.701 |
|
| 2023 |
Li J, Kumar A, Långström B, Nordberg A, Ågren H. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils. Acs Chemical Neuroscience. PMID 37639522 DOI: 10.1021/acschemneuro.3c00437 |
0.304 |
|
| 2023 |
Bucci M, Bluma M, Savitcheva I, Ashton NJ, Chiotis K, Matton A, Kivipelto M, Di Molfetta G, Blennow K, Zetterberg H, Nordberg A. Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic. Translational Psychiatry. 13: 268. PMID 37491358 DOI: 10.1038/s41398-023-02558-4 |
0.73 |
|
| 2023 |
Fontana IC, Scarpa M, Malarte ML, Rocha FM, Ausellé-Bosch S, Bluma M, Bucci M, Chiotis K, Kumar A, Nordberg A. Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective. Cells. 12. PMID 37296589 DOI: 10.3390/cells12111469 |
0.752 |
|
| 2023 |
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, ... ... Nordberg A, et al. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial. Jama Neurology. PMID 37155177 DOI: 10.1001/jamaneurol.2023.0997 |
0.705 |
|
| 2023 |
Almkvist O, Nordberg A. A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 89. PMID 37131241 DOI: 10.1186/s13195-023-01231-8 |
0.575 |
|
| 2023 |
Oeckl P, Bluma M, Bucci M, Halbgebauer S, Chiotis K, Sandebring-Matton A, Ashton NJ, Molfetta GD, Grötschel L, Kivipelto M, Blennow K, Zetterberg H, Savitcheva I, Nordberg A, Otto M. Blood β-synuclein is related to amyloid PET positivity in memory clinic patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37052206 DOI: 10.1002/alz.13046 |
0.684 |
|
| 2023 |
Fontana IC, Kumar A, Nordberg A. The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease. Nature Reviews. Neurology. PMID 36977843 DOI: 10.1038/s41582-023-00792-4 |
0.376 |
|
| 2023 |
Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A. Correction: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. Molecular Psychiatry. PMID 36890300 DOI: 10.1038/s41380-023-02021-2 |
0.399 |
|
| 2023 |
Mohanty R, Ferreira D, Nordberg A, Westman E. Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer's disease continuum: biological and methodological perspectives from disease heterogeneity. Alzheimer's Research & Therapy. 15: 37. PMID 36814346 DOI: 10.1186/s13195-023-01173-1 |
0.408 |
|
| 2023 |
Collij LE, Farrar G, Valléz García D, Bader I, Shekari M, Lorenzini L, Pemberton H, Altomare D, Pla S, Loor M, Markiewicz P, Yaqub M, Buckley C, Frisoni GB, Nordberg A, et al. The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact. Frontiers in Neurology. 13: 1063598. PMID 36761917 DOI: 10.3389/fneur.2022.1063598 |
0.67 |
|
| 2022 |
Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. Molecular Psychiatry. PMID 36447011 DOI: 10.1038/s41380-022-01875-2 |
0.341 |
|
| 2022 |
Ferreira D, Mohanty R, Murray ME, Nordberg A, Kantarci K, Westman E. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review. Acta Neuropathologica Communications. 10: 166. PMID 36376963 DOI: 10.1186/s40478-022-01471-z |
0.396 |
|
| 2022 |
Altomare D, Collij L, Caprioglio C, Scheltens P, van Berckel BNM, Alves IL, Berkhof J, de Gier Y, Garibotto V, Moro C, Poitrine L, Delrieu J, Payoux P, Saint-Aubert L, Molinuevo JL, ... ... Nordberg A, et al. Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35715930 DOI: 10.1002/alz.12696 |
0.675 |
|
| 2022 |
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, ... ... Nordberg A, et al. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. Jama Neurology. PMID 35099509 DOI: 10.1001/jamaneurol.2021.5216 |
0.539 |
|
| 2021 |
Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A. Lack of fibrillar amyloid plaques but hypometabolism and astrogliosis in autosomal dominant variant AßPParc Alzheimer's disease. Molecular Psychiatry. 26: 5471. PMID 35027661 DOI: 10.1038/s41380-021-01270-3 |
0.358 |
|
| 2021 |
Kumar A, Fontana IC, Nordberg A. Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. PMID 34931315 DOI: 10.1111/jnc.15565 |
0.401 |
|
| 2021 |
Bucci M, Chiotis K, Nordberg A. Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline. Molecular Psychiatry. PMID 34593971 DOI: 10.1038/s41380-021-01263-2 |
0.746 |
|
| 2021 |
Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter M, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. Correction to: The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34546388 DOI: 10.1007/s00259-021-05549-z |
0.667 |
|
| 2021 |
Colato E, Chiotis K, Ferreira D, Mazrina MS, Lemoine L, Mohanty R, Westman E, Nordberg A, Rodriguez-Vieitez E. Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 34511502 DOI: 10.3233/JAD-210614 |
0.768 |
|
| 2021 |
Murugan NA, Nordberg A, Ågren H. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy. Acs Chemical Neuroscience. 12: 2437-2447. PMID 34152739 DOI: 10.1021/acschemneuro.0c00340 |
0.326 |
|
| 2021 |
Almkvist O, Brüggen K, Nordberg A. Subcortical and Cortical Regions of Amyloid-β Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients. Journal of Alzheimer's Disease : Jad. PMID 33967046 DOI: 10.3233/JAD-201612 |
0.591 |
|
| 2021 |
Bellaver B, Ferrari-Souza JP, Uglione da Ros L, Carter SF, Rodriguez-Vieitez E, Nordberg A, Pellerin L, Rosa-Neto P, Leffa DT, Zimmer ER. Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis. Neurology. PMID 33952650 DOI: 10.1212/WNL.0000000000012109 |
0.653 |
|
| 2021 |
Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet. Neurology. PMID 33933186 DOI: 10.1016/S1474-4422(21)00066-1 |
0.351 |
|
| 2021 |
Kumar A, Koistinen NA, Malarte ML, Nennesmo I, Ingelsson M, Ghetti B, Lemoine L, Nordberg A. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer's disease brain. Molecular Psychiatry. PMID 33888872 DOI: 10.1038/s41380-021-01101-5 |
0.35 |
|
| 2021 |
Bucci M, Savitcheva I, Farrar G, Salvadó G, Collij L, Doré V, Gispert JD, Gunn R, Hanseeuw B, Hansson O, Shekari M, Lhommel R, Molinuevo JL, Rowe C, Sur C, ... ... Nordberg A, et al. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [F]flutemetamol amyloid PET images. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33844055 DOI: 10.1007/s00259-021-05311-5 |
0.317 |
|
| 2021 |
Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue. Journal of Alzheimer's Disease : Jad. PMID 33749648 DOI: 10.3233/JAD-201344 |
0.719 |
|
| 2021 |
Chiotis K, Dodich A, Boccardi M, Festari C, Drzezga A, Hansson O, Ossenkoppele R, Frisoni G, Garibotto V, Nordberg A. Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33723628 DOI: 10.1007/s00259-021-05277-4 |
0.734 |
|
| 2021 |
Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter MA, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, ... Nordberg A, et al. The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33688996 DOI: 10.1007/s00259-020-05120-2 |
0.689 |
|
| 2021 |
Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A. Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33590274 DOI: 10.1007/s00259-020-05156-4 |
0.393 |
|
| 2021 |
Villemagne VL, Barkhof F, Garibotto V, Landau SM, Nordberg A, van Berckel BNM. Molecular Imaging Approaches in Dementia. Radiology. 200028. PMID 33464184 DOI: 10.1148/radiol.2020200028 |
0.341 |
|
| 2020 |
Mohanty R, Mårtensson G, Poulakis K, Muehlboeck JS, Rodriguez-Vieitez E, Chiotis K, Grothe MJ, Nordberg A, Ferreira D, Westman E. Comparison of subtyping methods for neuroimaging studies in Alzheimer's disease: a call for harmonization. Brain Communications. 2: fcaa192. PMID 33305264 DOI: 10.1093/braincomms/fcaa192 |
0.699 |
|
| 2020 |
Sala A, Nordberg A, Rodriguez-Vieitez E. Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity. Molecular Psychiatry. PMID 33303945 DOI: 10.1038/s41380-020-00950-w |
0.359 |
|
| 2020 |
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, ... ... Nordberg A, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8 |
0.367 |
|
| 2020 |
Smailovic U, Koenig T, Savitcheva I, Chiotis K, Nordberg A, Blennow K, Winblad B, Jelic V. Regional disconnection in Alzheimer dementia and amyloid positive MCI: Association of EEG functional connectivity and brain glucose metabolism. Brain Connectivity. PMID 33073602 DOI: 10.1089/brain.2020.0785 |
0.74 |
|
| 2020 |
Malarte ML, Nordberg A, Lemoine L. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32970217 DOI: 10.1007/s00259-020-05035-y |
0.425 |
|
| 2020 |
Frisoni GB, Molinuevo JL, Altomare D, Carrera E, Barkhof F, Berkhof J, Delrieu J, Dubois B, Kivipelto M, Nordberg A, Schott JM, van der Flier WM, Vellas B, Jessen F, Scheltens P, et al. Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32815289 DOI: 10.1002/Alz.12132 |
0.357 |
|
| 2020 |
Perini G, Rodriguez-Vieitez E, Kadir A, Sala A, Savitcheva I, Nordberg A. Clinical impact of F-FDG-PET among memory clinic patients with uncertain diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32734458 DOI: 10.1007/S00259-020-04969-7 |
0.37 |
|
| 2020 |
Chiotis K, Savitcheva I, Poulakis K, Saint-Aubert L, Wall A, Antoni G, Nordberg A. [F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease. Molecular Psychiatry. PMID 32616831 DOI: 10.1038/S41380-020-0815-4 |
0.83 |
|
| 2020 |
Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9. Molecular Psychiatry. PMID 32581318 DOI: 10.1038/S41380-020-0817-2 |
0.72 |
|
| 2020 |
Vilaplana E, Rodriguez-Vieitez E, Ferreira D, Montal V, Almkvist O, Wall A, Lleó A, Westman E, Graff C, Fortea J, Nordberg A. Cortical microstructural correlates of astrocytosis in autosomal dominant Alzheimer disease. Neurology. PMID 32291295 DOI: 10.1212/Wnl.0000000000009405 |
0.636 |
|
| 2020 |
Kuang G, Murugan NA, Zhou Y, Nordberg A, Agren H. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils. Acs Chemical Neuroscience. PMID 32069017 DOI: 10.1021/Acschemneuro.9B00578 |
0.386 |
|
| 2020 |
Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. PMID 32047067 DOI: 10.1212/WNL.0000000000009058 |
0.315 |
|
| 2019 |
Karami A, Eriksdotter M, Kadir A, Almkvist O, Nordberg A, Darreh-Shori T. CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease. Frontiers in Molecular Neuroscience. 12: 239. PMID 31680850 DOI: 10.3389/Fnmol.2019.00239 |
0.62 |
|
| 2019 |
Lana E, Gellerbring A, Jung S, Nordberg A, Unger Lithner C, Darreh-Shori T. Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. Frontiers in Molecular Neuroscience. 12: 176. PMID 31417354 DOI: 10.3389/Fnmol.2019.00176 |
0.45 |
|
| 2019 |
Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Nordberg A, Viitanen M, Lannfelt L, Graff C. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes. Neurobiology of Aging. 82: 40-47. PMID 31386938 DOI: 10.1016/J.Neurobiolaging.2019.06.010 |
0.565 |
|
| 2019 |
Altomare D, Ferrari C, Caroli A, Galluzzi S, Prestia A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo ILH, Grimmer T, ... ... Nordberg A, et al. Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of Neurology. PMID 31267207 DOI: 10.1007/S00415-019-09441-7 |
0.751 |
|
| 2019 |
Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31230910 DOI: 10.1016/J.Jalz.2019.02.004 |
0.422 |
|
| 2019 |
Murugan NA, Chiotis K, Rodriguez-Vieitez E, Lemoine L, Ågren H, Nordberg A. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30919054 DOI: 10.1007/S00259-019-04305-8 |
0.69 |
|
| 2019 |
Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A. Clinical impact of [F]flutemetamol PET among memory clinic patients with an unclear diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30915522 DOI: 10.1007/S00259-019-04297-5 |
0.72 |
|
| 2019 |
Jonasson M, Wall A, Chiotis K, Leuzy A, Eriksson J, Antoni G, Nordberg A, Lubberink M. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [F]THK5317 PET. Neuroimage. Clinical. 22: 101681. PMID 30710871 DOI: 10.1016/J.Nicl.2019.101681 |
0.719 |
|
| 2019 |
Zou R, Kuang G, Agren H, Nordberg A, Långström B, Tu Y. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril. Acs Chemical Neuroscience. PMID 30698013 DOI: 10.1021/Acschemneuro.8B00662 |
0.38 |
|
| 2019 |
Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Molecular Psychiatry. PMID 30635637 DOI: 10.1038/S41380-018-0342-8 |
0.784 |
|
| 2019 |
Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/J.Molmed.2018.11.006 |
0.693 |
|
| 2019 |
Leuzy A, Cicognola C, Chiotis K, Saint-Aubert L, Lemoine L, Andreasen N, Zetterberg H, Ye K, Blennow K, Höglund K, Nordberg A. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30610252 DOI: 10.1007/S00259-018-4242-6 |
0.824 |
|
| 2019 |
Carter SF, Chiotis K, Nordberg A, Rodriguez-Vieitez E. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 46: 348-356. PMID 30515545 DOI: 10.1007/S00259-018-4217-7 |
0.803 |
|
| 2019 |
Darreh-Shori T, Kumar R, Kumar A, Murumkar P, Nag S, Jia Z, Arakawa R, Leuzy A, Lemoine L, Nordberg A, Yadav MR, Halldin C, Långström B. LIGANDS OF THE CORE ACETYLCHOLINE BIOSYNTHESIZING ENZYME, CHOLINE ACETYLTRANSFERASE, AS NOVEL AND POTENTIAL THERAPEUTIC AGENTS AND IN VIVO PET TRACERS FOR EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE Alzheimer's & Dementia. 15: P1630. DOI: 10.1016/J.Jalz.2019.06.4869 |
0.36 |
|
| 2018 |
Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, ... Nordberg A, et al. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease. Acta Neuropathologica Communications. 6: 130. PMID 30477568 DOI: 10.1186/S40478-018-0624-Z |
0.484 |
|
| 2018 |
Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Alves IL, ... ... Nordberg A, et al. AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30339801 DOI: 10.1016/J.Jalz.2018.09.003 |
0.416 |
|
| 2018 |
Oliveira F, Leuzy A, Castelhano J, Chiotis K, Hasselbalch SG, Rinne J, Mendonça A, Otto M, Lleó A, Santana I, Johansson J, Anderl-Straub S, Arnim C, Beer A, Blesa R, ... ... Nordberg A, et al. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species. Neuroimage. Clinical. 20: 603-610. PMID 30186764 DOI: 10.1016/J.Nicl.2018.08.023 |
0.767 |
|
| 2018 |
Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E. The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiology of Aging. 70: 18-29. PMID 29935417 DOI: 10.1016/J.Neurobiolaging.2018.05.028 |
0.477 |
|
| 2018 |
Lilja J, Leuzy A, Chiotis K, Savitcheva I, Sörensen J, Nordberg A. Spatial normalization of [F]flutemetamol PET images utilizing an adaptive principal components template. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903930 DOI: 10.2967/Jnumed.118.207811 |
0.706 |
|
| 2018 |
Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 232-236. PMID 29780868 DOI: 10.1016/J.Dadm.2018.01.007 |
0.742 |
|
| 2018 |
Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for C-THK5351 and C-PBB3 in the Alzheimer brain. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29752516 DOI: 10.1007/S00259-018-4012-5 |
0.785 |
|
| 2018 |
Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45. PMID 29747683 DOI: 10.1186/S13195-018-0374-Y |
0.769 |
|
| 2018 |
Murugan NA, Nordberg A, Ågren H. Different PET tau tracers bind to multiple binding sites on the tau fibril : Insight from computational modeling. Acs Chemical Neuroscience. PMID 29630333 DOI: 10.1021/Acschemneuro.8B00093 |
0.327 |
|
| 2018 |
Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, ... ... Nordberg A, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009 |
0.566 |
|
| 2018 |
Rodriguez-Vieitez E, Nordberg A. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach. Methods in Molecular Biology (Clifton, N.J.). 1750: 231-251. PMID 29512077 DOI: 10.1007/978-1-4939-7704-8_16 |
0.533 |
|
| 2018 |
Ni R, Ji B, Ono M, Sahara N, Zhang MR, Aoki I, Nordberg A, Suhara T, Higuchi M. Comparative in-vitro and in-vivo quantifications of pathological tau deposits and their association with neurodegeneration in tauopathy mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29419480 DOI: 10.2967/Jnumed.117.201632 |
0.723 |
|
| 2017 |
Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29268078 DOI: 10.1016/J.Jalz.2017.11.008 |
0.826 |
|
| 2017 |
Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains. Alzheimer's Research & Therapy. 9: 96. PMID 29229003 DOI: 10.1186/S13195-017-0325-Z |
0.411 |
|
| 2017 |
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Nordberg A, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391 |
0.575 |
|
| 2017 |
Balamurugan K, Murugan NA, Långström B, Nordberg A, Ågren H. Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers- Insight from Molecular Modeling Studies. Acs Chemical Neuroscience. PMID 28898051 DOI: 10.1021/Acschemneuro.7B00215 |
0.428 |
|
| 2017 |
Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X |
0.799 |
|
| 2017 |
Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. 59: 603-614. PMID 28671117 DOI: 10.3233/Jad-170158 |
0.799 |
|
| 2017 |
Heurling K, Leuzy A, Jonasson M, Frick A, Zimmer ER, Nordberg A, Lubberink M. Quantitative positron emission tomography in brain research. Brain Research. PMID 28652218 DOI: 10.1016/J.Brainres.2017.06.022 |
0.431 |
|
| 2017 |
Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E, Leuzy A, Almkvist O, Savitcheva I, Jonasson M, Lubberink M, Wall A, Antoni G, Nordberg A. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular Psychiatry. 23: 1666-1673. PMID 28507319 DOI: 10.1038/Mp.2017.108 |
0.851 |
|
| 2017 |
Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Scientific Reports. 7: 45496. PMID 28374768 DOI: 10.1038/Srep45496 |
0.718 |
|
| 2017 |
Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 285-295. PMID 28341066 DOI: 10.1016/J.Jalz.2016.09.009 |
0.461 |
|
| 2017 |
Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, ... Nordberg A, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 274-284. PMID 28341065 DOI: 10.1016/J.Jalz.2016.09.008 |
0.443 |
|
| 2017 |
Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227. PMID 28317650 DOI: 10.1016/J.Neurobiolaging.2016.07.012 |
0.825 |
|
| 2017 |
Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, Nobili F, Ratib O. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 183-195. PMID 28317648 DOI: 10.1016/J.Neurobiolaging.2016.03.033 |
0.462 |
|
| 2017 |
Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging: present and future directions. Molecular Neurodegeneration. 12: 19. PMID 28219440 DOI: 10.1186/S13024-017-0162-3 |
0.839 |
|
| 2017 |
Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson DW, Trojanowski JQ, Lee VM, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten JC, Nordberg A, Suhara T, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain : a Journal of Neurology. PMID 28087578 DOI: 10.1093/Brain/Aww339 |
0.718 |
|
| 2017 |
Kuang G, Zhou Y, Zou R, Halldin C, Nordberg A, Långström B, Ågren H, Tu Y. Characterization of the binding mode of the PET tracer [18F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor Rsc Advances. 7: 19787-19793. DOI: 10.1039/C7Ra00496F |
0.319 |
|
| 2017 |
Frisoni GB, Barkhof F, Farrar G, Raffa N, Gismondi R, Schmidt ME, Berkhof J, Boccardi M, Walker Z, Scheltens P, Schott JM, Molinuevo JL, Vellas B, Jessen F, Nordberg A, et al. THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET Alzheimer's & Dementia. 13: P1523. DOI: 10.1016/J.Jalz.2017.07.653 |
0.393 |
|
| 2017 |
Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [IC-P-178]: HEAD-TO-HEAD IN VIVO
COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11
C]THK5351 VERSUS [11
C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P133-P133. DOI: 10.1016/J.Jalz.2017.06.2553 |
0.791 |
|
| 2017 |
Leuzy A, Chiotis K, Jelic V, Andersen P, Friman J, Lilja J, Savitcheva I, Nordberg A. Investigating The Clinical Impact Of [18F]Flutemetamol Pet In A Tertiary Memory Clinic Setting In Patients With Uncertain Diagnosis Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2288 |
0.682 |
|
| 2017 |
Lemoine L, Gillberg P, Svedberg M, Stepanov V, Nag S, Tian H, Higuchi M, Halldin C, Nordberg A. [P4-274]: COMPARISON OF BINDING PROPERTIES OF THK5117, THK5351, PBB3 AND T807 IN AUTOPSIES OF ALZHEIMER DISEASE CASES Alzheimer's & Dementia. 13: P1390-P1390. DOI: 10.1016/J.Jalz.2017.06.2143 |
0.348 |
|
| 2017 |
Chiotis K, Stenkrona P, Almkvist O, Arakawa R, Takano A, Stepanov V, Varrone A, Higuchi M, Halldin C, Nordberg A. [P2-366]: HEAD-TO-HEAD IN VIVO
COMPARISON OF TAU-SPECIFIC PET TRACERS IN ALZHEIMER's DISEASE: [11
C]THK5351 VERSUS [11
C]PBB3 PET IMAGING Alzheimer's & Dementia. 13: P765-P765. DOI: 10.1016/j.jalz.2017.06.1021 |
0.613 |
|
| 2016 |
Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, Furumoto S, Mitsios N, Mulder J, Långström B, Nordberg A, Halldin C. Development of [(11)C]/[(3)H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand. Nuclear Medicine and Biology. 46: 50-53. PMID 28013122 DOI: 10.1016/J.Nucmedbio.2016.12.004 |
0.42 |
|
| 2016 |
Ni R, Gillberg PG, Bogdanovic N, Viitanen M, Myllykangas L, Nennesmo I, Långström B, Nordberg A. Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27693181 DOI: 10.1016/J.Jalz.2016.08.006 |
0.738 |
|
| 2016 |
Saint-Aubert L, Almkvist O, Chiotis K, Almeida R, Wall A, Nordberg A. Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38. PMID 27683159 DOI: 10.1186/S13195-016-0204-Z |
0.849 |
|
| 2016 |
Natarajan AM, Halldin C, Nordberg A, Långström B, Ågren H. The Culprit Is in the Cave: The Core Sites Explain the Binding Profiles of Amyloid Specific Tracers. The Journal of Physical Chemistry Letters. PMID 27498616 DOI: 10.1021/Acs.Jpclett.6B01586 |
0.34 |
|
| 2016 |
Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1316-22. PMID 27481605 DOI: 10.2967/Jnumed.116.174615 |
0.383 |
|
| 2016 |
Leuzy A, Chiotis K, Hasselbalch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-Branco M, Santana I, Johansson J, Anderl-Straub S, von Arnim CA, Beer A, Blesa R, Fortea J, ... ... Nordberg A, et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study. Brain : a Journal of Neurology. PMID 27401520 DOI: 10.1093/Brain/Aww160 |
0.714 |
|
| 2016 |
Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, ... Nordberg A, et al. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device. Alzheimer's Research & Therapy. 8: 30. PMID 27389402 DOI: 10.1186/S13195-016-0195-9 |
0.563 |
|
| 2016 |
Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Wall A, Nordberg A. Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27107028 DOI: 10.1177/0271678X16645593 |
0.822 |
|
| 2016 |
Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1686-99. PMID 26996778 DOI: 10.1007/S00259-016-3363-Z |
0.846 |
|
| 2016 |
Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, ... ... Nordberg A, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4 |
0.422 |
|
| 2016 |
Rodriguez-Vieitez E, Carter SF, Chiotis K, Saint-Aubert L, Leuzy A, Schöll M, Almkvist O, Wall A, Långström B, Nordberg A. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912447 DOI: 10.2967/Jnumed.115.168732 |
0.814 |
|
| 2016 |
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Graff C, Wall A, Långström B, Nordberg A. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 26813969 DOI: 10.1093/Brain/Awv404 |
0.831 |
|
| 2016 |
Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson JP, Sörensen J, Antoni G, Nordberg A, Lubberink M. Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26795290 DOI: 10.2967/Jnumed.115.158519 |
0.84 |
|
| 2016 |
Heurling K, Leuzy A, Zimmer ER, Lubberink M, Nordberg A. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis. European Journal of Nuclear Medicine and Molecular Imaging. 43: 362-73. PMID 26440450 DOI: 10.1007/S00259-015-3208-1 |
0.443 |
|
| 2016 |
Chiotis K, Saint-Aubert L, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau pet imaging in neurodegenerative tauopathies – a multimodal paradigm Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.125 |
0.813 |
|
| 2016 |
Nordberg A. Molecular PET imaging as correlates to drug response Neurobiology of Aging. 39: S23-S24. DOI: 10.1016/J.Neurobiolaging.2016.01.105 |
0.32 |
|
| 2016 |
Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Nordberg A. Comparison of Early-Phase (S)-[18F]THK5117 and [11C]PIB PET imaging to assess brain perfusion in Alzheimer’s disease Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.095 |
0.817 |
|
| 2016 |
Nordberg A. Longitudinal studies of regional tau deposition in brain by PET Neurobiology of Aging. 39: S19. DOI: 10.1016/J.Neurobiolaging.2016.01.087 |
0.419 |
|
| 2016 |
Leuzy A, Chiotis K, Pannee J, Hasselbalch S, Rinne J, Castelo-Branco M, Mendonca A, Santana I, Bisa AL, Johansson J, Otto M, Portelius E, Zetterberg H, Blennow K, Nordberg A. Improved concordance between [11C]PIB PET and CSF Aβ42 using Aβ42/Aβ40: findings from a multicentre European memory clinic population Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.084 |
0.725 |
|
| 2016 |
Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. In vitro characterization of fibrillar amyloid, tau deposits, and activated astrocytes in Arctic APP and sporadic Alzheimer's disease brain using, 3H-PIB and 3H-THK5117 and 3H-Deprenyl in comparison to immunostaining Neurobiology of Aging. 39: S15. DOI: 10.1016/J.Neurobiolaging.2016.01.073 |
0.389 |
|
| 2016 |
Rodriguez-Vieitez E, Leuzy A, Chiotis K, Saint-Aubert L, Almkvist O, Wall A, Nordberg A. Early-Phase [11C]Pib Pet Is Comparable To [18F]Fdg Pet As A Marker Of Disease Progression In Alzheimer'S Disease Alzheimers & Dementia. 12: 1171. DOI: 10.1016/J.Jalz.2016.07.094 |
0.833 |
|
| 2016 |
Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. P1-105: In vitro Characterization of Fibrillar Amyloid, TAU Deposition, and Activated Astrocytes in Arctic Alzheimer's Disease Brain in Comparison With Sporadic Alzheimer's Disease Brain Using 3H-PIB, 3H-THK5117 and 3H-DEPRENYL Alzheimer's & Dementia. 12: P442-P442. DOI: 10.1016/J.Jalz.2016.06.853 |
0.424 |
|
| 2016 |
Nordberg A, Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Almkvist O, Wall A, Antoni G. Longitudinal Changes In Regional Tau Deposition In Alzheimer'S Disease And Other Tauopathies Measured By [18F]-Tkh5317 Pet In A Multi-Tracer Design Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.645 |
0.834 |
|
| 2016 |
Lemoine L, Ingelsson M, Nennesmo I, Gillberg P, Nordberg A. IC-P-170: In Vitro
Characterization of Fibrillar Amyloid, TAU Deposition, and Activated Astrocytes in Arctic AD Brain in Comparison With Sporadic AD Brain Using 3H-PIB, 3H-THK5117 and 3H-Deprenyl Alzheimer's & Dementia. 12: P124-P124. DOI: 10.1016/J.Jalz.2016.06.201 |
0.392 |
|
| 2016 |
Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Wall A, Antoni G, Nordberg A. Tau Pet Imaging In Non-Alzheimer’S Disease Dementia: A Multimodal Paradigm Alzheimers & Dementia. 12: 137. DOI: 10.1016/J.Jalz.2016.06.1925 |
0.828 |
|
| 2016 |
Saint-Aubert L, Chiotis K, Wall A, Almkvist O, Nordberg A. P1-306: Association Between in Vivo TAU Deposition Measured Using [18F]THK5317 Pet and Cognitive Functions in Alzheimer's Disease Alzheimer's & Dementia. 12: P539-P540. DOI: 10.1016/J.Jalz.2016.06.1056 |
0.838 |
|
| 2015 |
Schöll M, Carter SF, Westman E, Rodriguez-Vieitez E, Almkvist O, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific Reports. 5: 16404. PMID 26553227 DOI: 10.1038/Srep16404 |
0.84 |
|
| 2015 |
Kumar R, Nordberg A, Darreh-Shori T. Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs. Brain : a Journal of Neurology. PMID 26525916 DOI: 10.1093/Brain/Awv318 |
0.372 |
|
| 2015 |
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081 |
0.698 |
|
| 2015 |
Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment. Journal of Alzheimer's Disease : Jad. 47: 691-704. PMID 26401704 DOI: 10.3233/Jad-132474 |
0.661 |
|
| 2015 |
Farid K, Carter SF, Rodriguez-Vieitez E, Almkvist O, Andersen P, Wall A, Blennow K, Portelius E, Zetterberg H, Nordberg A. Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition. Journal of Alzheimer's Disease : Jad. 47: 661-7. PMID 26401701 DOI: 10.3233/Jad-141965 |
0.781 |
|
| 2015 |
Kuang G, Murugan NA, Tu Y, Nordberg A, Ågren H. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods. The Journal of Physical Chemistry. B. 119: 11560-7. PMID 26266837 DOI: 10.1021/Acs.Jpcb.5B05964 |
0.349 |
|
| 2015 |
Lilja AM, Malmsten L, Röjdner J, Voytenko L, Verkhratsky A, Ögren SO, Nordberg A, Marutle A. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs. Neural Plasticity. 2015: 370432. PMID 26257960 DOI: 10.1155/2015/370432 |
0.35 |
|
| 2015 |
Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue. Acta Neuropathologica Communications. 3: 40. PMID 26134112 DOI: 10.1186/S40478-015-0220-4 |
0.76 |
|
| 2015 |
Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-506. PMID 26130168 DOI: 10.1007/S00259-015-3115-5 |
0.814 |
|
| 2015 |
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, ... ... Nordberg A, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669 |
0.635 |
|
| 2015 |
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Nordberg A, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668 |
0.523 |
|
| 2015 |
Rodriguez-Vieitez E, Ni R, Gulyás B, Tóth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1119-32. PMID 25893384 DOI: 10.1007/S00259-015-3047-0 |
0.711 |
|
| 2015 |
Andreasen N, Simeoni M, Ostlund H, Lisjo PI, Fladby T, Loercher AE, Byrne GJ, Murray F, Scott-Stevens PT, Wallin A, Zhang YY, Bronge LH, Zetterberg H, Nordberg AK, Yeo AJ, et al. First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study. Plos One. 10: e0098153. PMID 25789616 DOI: 10.1371/journal.pone.0098153 |
0.315 |
|
| 2015 |
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, ... Nordberg A, et al. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25676388 DOI: 10.1016/J.Jalz.2014.11.008 |
0.394 |
|
| 2015 |
Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 1077-88. PMID 25649653 DOI: 10.3233/Jad-142952 |
0.855 |
|
| 2015 |
Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25646957 DOI: 10.1016/J.Jalz.2014.12.001 |
0.809 |
|
| 2015 |
Nordberg A. Dementia in 2014. Towards early diagnosis in Alzheimer disease. Nature Reviews. Neurology. 11: 69-70. PMID 25623789 DOI: 10.1038/Nrneurol.2014.257 |
0.463 |
|
| 2015 |
Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression. Neurology. 84: 508-15. PMID 25568301 DOI: 10.1212/Wnl.0000000000001209 |
0.742 |
|
| 2015 |
Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al-Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, ... ... Nordberg A, et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. European Journal of Nuclear Medicine and Molecular Imaging. 42: 438-46. PMID 25412766 DOI: 10.1007/S00259-014-2955-8 |
0.48 |
|
| 2015 |
Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, ... ... Nordberg A, et al. The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 195-206.e1. PMID 25150733 DOI: 10.1016/J.Jalz.2014.06.006 |
0.517 |
|
| 2015 |
Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Blennow K, Langstrom B, Zetterberg H. Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment Journal of Alzheimer's Disease. 47: 691-704. DOI: 10.3233/JAD-132474 |
0.542 |
|
| 2015 |
Ni R, Gillberg P, Viitanen M, Myllykangas L, Bogdanovic N, Nennesmo I, Långström B, Nordberg A. P4-254: Characterization of regional binding of clinical amyloid tracers in autosomal dominant and sporadic Alzheimer's disease brains and their interactions with resveratrol Alzheimer's & Dementia. 11: P878-P878. DOI: 10.1016/J.Jalz.2015.08.083 |
0.715 |
|
| 2015 |
Nordberg A. O4-07-05: 18F-(S).THK5117 as a PET tracer for tau pathology in Alzheimer's disease and non-alzheimer's disease dementia Alzheimer's & Dementia. 11: P285-P285. DOI: 10.1016/J.Jalz.2015.07.385 |
0.495 |
|
| 2015 |
Caroli A, Galluzzi S, Ferrari C, Prestia A, Flier WMvd, Ossenkoppele R, Berckel BNMv, Barkhof F, Teunissen CE, Wall A, Carter SF, Scholl M, Choo IH, Grimmer T, Redolfi A, ... Nordberg A, et al. Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.064 |
0.744 |
|
| 2015 |
Rodriguez-Vieitez E, Carter SF, Saint-Aubert L, Almkvist O, Farid K, Schöll M, Chiotis K, Thordardottir S, Wall A, Graff C, Långström B, Nordberg A. IC-P-126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal-dominant and sporadic Alzheimer's disease Alzheimer's & Dementia. 11: P86-P86. DOI: 10.1016/J.Jalz.2015.06.148 |
0.83 |
|
| 2015 |
Varrone A, Nordberg A. Molecular imaging of neuroinflammation in Alzheimer’s disease Clinical and Translational Imaging. 3: 437-447. DOI: 10.1007/S40336-015-0137-8 |
0.505 |
|
| 2015 |
Nordberg A. The use of amyloid imaging in clinical praxis: a critical review Clinical and Translational Imaging. 3: 7-11. DOI: 10.1007/S40336-015-0100-8 |
0.525 |
|
| 2015 |
Chiotis K, Carter SF, Farid K, Savitcheva I, Nordberg A. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging European Journal of Nuclear Medicine and Molecular Imaging. 42: 1492-1506. DOI: 10.1007/s00259-015-3115-5 |
0.647 |
|
| 2014 |
Almkvist O, Kadir A, Nordberg A. Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case. Neurocase. 1-10. PMID 25494540 DOI: 10.1080/13554794.2014.979835 |
0.648 |
|
| 2014 |
Murugan NA, Zale?ny R, Kongsted J, Nordberg A, Ågren H. Promising two-photon probes for in vivo detection of β amyloid deposits. Chemical Communications (Cambridge, England). 50: 11694-7. PMID 25141215 DOI: 10.1039/C4Cc03897E |
0.375 |
|
| 2014 |
Verkhratsky A, Marutle A, Rodríguez-Arellano JJ, Nordberg A. Glial Asthenia and Functional Paralysis: A New Perspective on Neurodegeneration and Alzheimer's Disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. PMID 25125026 DOI: 10.1177/1073858414547132 |
0.413 |
|
| 2014 |
Choo IL, Carter SF, Schöll ML, Nordberg A. Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2120-6. PMID 25077930 DOI: 10.1007/S00259-014-2859-7 |
0.796 |
|
| 2014 |
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, ... ... Nordberg A, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0 |
0.478 |
|
| 2014 |
Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B. Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275: 204-13. PMID 24605805 DOI: 10.1111/Joim.12199 |
0.428 |
|
| 2014 |
Nordberg A. Molecular imaging in sporadic Alzheimer's disease populations and those genetically at risk. Neuro-Degenerative Diseases. 13: 160-2. PMID 24434947 DOI: 10.1159/000356333 |
0.504 |
|
| 2014 |
Darreh-Shori T, Hosseini SM, Nordberg A. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors. Journal of Alzheimer's Disease : Jad. 39: 423-40. PMID 24217282 DOI: 10.3233/Jad-130845 |
0.374 |
|
| 2014 |
Nordberg A. The value of multi-PET tracers imaging for Alzheimer's disease therapy evolution Neurobiology of Aging. 35. DOI: 10.1016/J.Neurobiolaging.2014.01.099 |
0.443 |
|
| 2014 |
Nordberg A. Astroglia and microglia imaging markers in the progression of Alzheimer's disease Neurobiology of Aging. 35: S17-S18. DOI: 10.1016/J.Neurobiolaging.2014.01.098 |
0.414 |
|
| 2014 |
Lemoine L, Gillberg P, Marutle A, Antoni G, Eriksson J, Estrada S, Nennesmo I, Okamura N, Nordberg A. IC-P-212: CHARACTERIZATION OF THK5117 BINDING IN AD BRAIN TISSUE: IMPLICATION FOR DEVELOPMENT OF PET TAU IMAGING Alzheimer's & Dementia. 10: P115-P115. DOI: 10.1016/j.jalz.2014.05.220 |
0.329 |
|
| 2014 |
Chiotis K, Carter SF, Farid K, Nordberg A. P3-218: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P710-P711. DOI: 10.1016/j.jalz.2014.05.1309 |
0.616 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306 |
0.708 |
|
| 2014 |
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Per A, Kadir A, Linderoth B, Andreasen N, Nordberg A, Wall A, Wahlund L, Seiger Å, Wahlberg L, Darreh-Shori T, Eriksdotter M. Ngf Cell Therapy In Ad Patients: Effects On Csf Cholinergic Biomarkers Alzheimers & Dementia. 10: 620. DOI: 10.1016/J.Jalz.2014.05.1067 |
0.347 |
|
| 2014 |
Eyjolfsdottir H, Per A, Lind G, Linderoth B, Karami A, Almkvist O, Andreasen N, Blennow K, Jelic V, Nordberg A, Sundström E, Wahlund L, Wall A, Wiberg MK, Winblad B, et al. Encapsulated Cell Biodelivery Of Ngf To Cholinergic Basal Forebrain In Alzheimer'S Disease Patients: A Dose-Escalation Study Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1063 |
0.575 |
|
| 2014 |
Chiotis K, Carter SF, Farid K, Nordberg A. IC-P-025: AGE IS A SIGNIFICANT FACTOR IN DETERMINING PATHOLOGICAL POSITIVITY MEASURED WITH [18F]FLORBETAPIR PET Alzheimer's & Dementia. 10: P18-P18. DOI: 10.1016/J.Jalz.2014.05.029 |
0.771 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023 |
0.718 |
|
| 2014 |
Ni R, Rodriguez-Vieitez E, Voytenko L, Marutle A, Nordberg A. Different Time Course Of Astrocytosis And Amyloid Deposition In Alzheimer'S Appswe Transgenice Mice: A Multi-Tracer Micropet Study Alzheimers & Dementia. 10: 253. DOI: 10.1016/J.Jalz.2014.04.394 |
0.7 |
|
| 2014 |
Caroli A, Frisoni G, Prestia A, Galluzzi S, Ferrari C, Flier WMVd, Ossenkoppele R, Berckel Bv, Barkhof F, Teunissen C, Wall A, Carter SF, Schöll M, Choo IH, Grimmer T, ... Nordberg A, et al. Mild Cognitive Impairment With Suspected Non Ad Pathology (Snap): Prediction Of Progression To Dementia Alzheimers & Dementia. 10: 19-19. DOI: 10.1016/J.Jalz.2014.04.230 |
0.761 |
|
| 2014 |
Lemoine L, Gillberg P, Marutle A, Antoni G, Eriksson J, Estrada S, Nennesmo I, Okamura N, Nordberg A. O1-12-04: CHARACTERIZATION OF THK5117 BINDING IN AD BRAIN TISSUE: IMPLICATION FOR DEVELOPMENT OF PET TAU IMAGING Alzheimer's & Dementia. 10: P155-P155. DOI: 10.1016/J.Jalz.2014.04.125 |
0.404 |
|
| 2013 |
Nordberg A, Ballard C, Bullock R, Darreh-Shori T, Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease. The Primary Care Companion For Cns Disorders. 15. PMID 23930233 DOI: 10.4088/Pcc.12R01412 |
0.439 |
|
| 2013 |
Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8 |
0.57 |
|
| 2013 |
Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain. Journal of Neuroinflammation. 10: 90. PMID 23880036 DOI: 10.1186/1742-2094-10-90 |
0.734 |
|
| 2013 |
Darreh-Shori T, Vijayaraghavan S, Aeinehband S, Piehl F, Lindblom RP, Nilsson B, Ekdahl KN, Långström B, Almkvist O, Nordberg A. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease. Neurobiology of Aging. 34: 2465-81. PMID 23759148 DOI: 10.1016/J.Neurobiolaging.2013.04.027 |
0.577 |
|
| 2013 |
Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue. Brain : a Journal of Neurology. 136: 2217-27. PMID 23757761 DOI: 10.1093/Brain/Awt142 |
0.696 |
|
| 2013 |
Lilja AM, Röjdner J, Mustafiz T, Thomé CM, Storelli E, Gonzalez D, Unger-Lithner C, Greig NH, Nordberg A, Marutle A. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels. Plos One. 8: e58752. PMID 23554921 DOI: 10.1371/Journal.Pone.0058752 |
0.379 |
|
| 2013 |
Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease. Neurology. 80: 1048-56. PMID 23390179 DOI: 10.1212/Wnl.0B013E3182872830 |
0.734 |
|
| 2013 |
Lilja AM, Luo Y, Yu QS, Röjdner J, Li Y, Marini AM, Marutle A, Nordberg A, Greig NH. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease. Plos One. 8: e54887. PMID 23382994 DOI: 10.1371/Journal.Pone.0054887 |
0.359 |
|
| 2013 |
Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014 |
0.72 |
|
| 2013 |
Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's Disease : Jad. 33: 929-39. PMID 23047371 DOI: 10.3233/Jad-2012-121489 |
0.799 |
|
| 2013 |
Ni R, Marutle A, Nordberg A. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 33: 841-51. PMID 23042213 DOI: 10.3233/Jad-2012-121447 |
0.716 |
|
| 2013 |
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2 |
0.804 |
|
| 2013 |
Chiotis K, Carter S, Nordberg A. P1-320: Comparison of PiB-PET data to florbetapir-PET data acquired from cohorts at different research sites Alzheimer's & Dementia. 9: P275-P275. DOI: 10.1016/J.Jalz.2013.05.546 |
0.758 |
|
| 2013 |
Chiotis K, Carter S, Nordberg A. Comparison of PiB-PET data to florbetapir-PET data acquired from different patient cohorts at different research sites Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.007 |
0.774 |
|
| 2013 |
Schöll M, Carter S, Westman E, Almkvist O, Wall A, Graff C, Långström B, Nordberg A. O4-07-02: Longitudinal multi-tracer positron emission tomography studies of astrocytosis, fibrillar amlyloid deposition and cerebral glucose metabolism during development of early-onset familial Alzheimer's disease Alzheimer's & Dementia. 9: P695-P695. DOI: 10.1016/J.Jalz.2013.04.372 |
0.799 |
|
| 2013 |
Rodriguez-Vieitez E, Ni R, Gulyás B, Toth M, Häggkvist J, Halldin C, Voytenko L, Marutle A, Nordberg A. Astrocytosis precedes amyloid deposition in Alzheimer’s disease Tg2576 APPswe transgenic mice: A multitracer microPET imaging study Alzheimers & Dementia. 9: 337. DOI: 10.1016/J.Jalz.2013.04.197 |
0.671 |
|
| 2012 |
Sugaya K, Youdim MB, Nordberg A, Rao KS. Neuroprotection and neuroregeneration in Alzheimer's disease. International Journal of Alzheimer's Disease. 2012: 864138. PMID 22737586 DOI: 10.1155/2012/864138 |
0.424 |
|
| 2012 |
Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 79: 229-36. PMID 22700814 DOI: 10.1212/Wnl.0B013E31825Fdf18 |
0.628 |
|
| 2012 |
Eriksdotter-Jönhagen M, Linderoth B, Lind G, Aladellie L, Almkvist O, Andreasen N, Blennow K, Bogdanovic N, Jelic V, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, et al. Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 33: 18-28. PMID 22377499 DOI: 10.1159/000336051 |
0.609 |
|
| 2012 |
Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, ... ... Nordberg A, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0 |
0.572 |
|
| 2012 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 37-46. PMID 22213821 DOI: 10.2967/Jnumed.110.087031 |
0.789 |
|
| 2012 |
Forsberg A, Engler H, Blomquist G, Långström B, Nordberg A. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochimica Et Biophysica Acta. 1822: 380-5. PMID 22115832 DOI: 10.1016/J.Bbadis.2011.11.006 |
0.523 |
|
| 2012 |
Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 443-58. PMID 22012848 DOI: 10.3233/Jad-2011-111088 |
0.307 |
|
| 2012 |
Bao F, Wicklund L, Lacor PN, Klein WL, Nordberg A, Marutle A. Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity. Neurobiology of Aging. 33: 825.e1-13. PMID 21683475 DOI: 10.1016/J.Neurobiolaging.2011.05.003 |
0.463 |
|
| 2012 |
Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of Aging. 33: 198.e1-14. PMID 20688420 DOI: 10.1016/J.Neurobiolaging.2010.06.015 |
0.687 |
|
| 2012 |
Nordberg A. 59 A decade of amyloid PET imaging: advances in neuroinflammation Neurobiology of Aging. 33: S26. DOI: 10.1016/J.Neurobiolaging.2012.01.077 |
0.431 |
|
| 2012 |
Wicklund L, Lilja A, Nordberg A, Marutle A. 48 Revamping the cholinergic system in Alzheimer's disease: Experience from stem cell studies Neurobiology of Aging. 33: S21. DOI: 10.1016/J.Neurobiolaging.2012.01.066 |
0.355 |
|
| 2011 |
Nordberg A. Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development. Alzheimer's Research & Therapy. 3: 34. PMID 22136152 DOI: 10.1186/Alzrt96 |
0.532 |
|
| 2011 |
Lithner CU, Hedberg MM, Nordberg A. Transgenic mice as a model for Alzheimer's disease. Current Alzheimer Research. 8: 818-31. PMID 21592052 DOI: 10.2174/156720511798192736 |
0.426 |
|
| 2011 |
Mustafiz T, Portelius E, Gustavsson MK, Hölttä M, Zetterberg H, Blennow K, Nordberg A, Lithner CU. Characterization of the brain β-amyloid isoform pattern at different ages of Tg2576 mice. Neuro-Degenerative Diseases. 8: 352-63. PMID 21346320 DOI: 10.1159/000323871 |
0.46 |
|
| 2011 |
Shafaati M, Marutle A, Pettersson H, Lövgren-Sandblom A, Olin M, Pikuleva I, Winblad B, Nordberg A, Björkhem I. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. Journal of Lipid Research. 52: 1004-10. PMID 21335619 DOI: 10.1194/Jlr.M014548 |
0.414 |
|
| 2011 |
Schöll M, Almkvist O, Bogdanovic N, Wall A, Långström B, Viitanen M, Nordberg A. Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers. Journal of Alzheimer's Disease : Jad. 24: 495-506. PMID 21297272 DOI: 10.3233/Jad-2011-101563 |
0.611 |
|
| 2011 |
Keller C, Kadir A, Forsberg A, Porras O, Nordberg A. Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 24: 109-23. PMID 21157026 DOI: 10.3233/Jad-2010-101290 |
0.444 |
|
| 2011 |
Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Brain : a Journal of Neurology. 134: 301-17. PMID 21149866 DOI: 10.1093/Brain/Awq349 |
0.656 |
|
| 2011 |
Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, et al. Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology. 95: 579-93. PMID 21130138 DOI: 10.1016/J.Pneurobio.2010.11.005 |
0.414 |
|
| 2011 |
Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 23: 335-47. PMID 21116052 DOI: 10.3233/Jad-2010-101242 |
0.427 |
|
| 2011 |
Darreh-Shori T, Forsberg A, Modiri N, Andreasen N, Blennow K, Kamil C, Ahmed H, Almkvist O, Långström B, Nordberg A. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging. 32: 2320.e15-32. PMID 20538374 DOI: 10.1016/J.Neurobiolaging.2010.04.028 |
0.666 |
|
| 2011 |
Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Långström B, Lannfelt L, Graff C, Nordberg A. Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiology of Aging. 32: 1388-99. PMID 19796846 DOI: 10.1016/J.Neurobiolaging.2009.08.016 |
0.641 |
|
| 2011 |
Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A. The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiology of Aging. 32: 1236-48. PMID 19713000 DOI: 10.1016/J.Neurobiolaging.2009.07.015 |
0.425 |
|
| 2011 |
Ng Y, Nordberg A, Carter S, Schöll M, Kadir A. P4-358: Different hierarchical cytoarchitectonic sub-type vulnerability to Aβ-deposits and gray matter loss in AD and MCI patients: A comparison between a young and old cohort Alzheimer's & Dementia. 7: e37-e38. DOI: 10.1016/J.Jalz.2011.09.173 |
0.753 |
|
| 2011 |
Thomé C, Ni R, Gillberg P, Marutle A, Nordberg A. P4-301: Evolution of fibrillar amyloid in relation to astro- and microgliosis and alterations in α7 nicotinic receptors in Alzheimer APPswe mice as studied with multi-tracer concept Alzheimer's & Dementia. 7: e16-e17. DOI: 10.1016/J.Jalz.2011.09.046 |
0.674 |
|
| 2011 |
Schöll M, Almkvist O, Graff C, Nordberg A. O2-06-08: Amyloid imaging in members of a family harbouring the Arctic APP mutation Alzheimer's & Dementia. 7: S303-S303. DOI: 10.1016/J.Jalz.2011.05.880 |
0.668 |
|
| 2011 |
Carter SF, Nordberg A, Schöll M, Almkvist O, Wall A, Engler H, Långström B. O1-07-05: Investigating astrocytosis with 11C-deuterium-L-Deprenyl in mild cognitive impairment and mild Alzheimer's disease: A multi tracer PET paradigm combining 11C-PIB and 18F-FDG Alzheimer's & Dementia. 7: S110-S110. DOI: 10.1016/J.Jalz.2011.05.276 |
0.813 |
|
| 2011 |
Lithner CU, Hernandez C, Sweatt JD, Nordberg A. O3-05-05: Epigenetic effects of Aβ and the implication on the pathophysiology in Alzheimer's disease Alzheimer's & Dementia. 7: S508-S508. DOI: 10.1016/J.Jalz.2011.05.1420 |
0.401 |
|
| 2011 |
Ni R, Marutle A, Nordberg A. P2-487: Alpha7 nicotinic receptor agonists interrupt the interaction between fibrillar amyloid and nicotinic receptor in Alzheimer's brain Alzheimer's & Dementia. 7: S468-S468. DOI: 10.1016/J.Jalz.2011.05.1358 |
0.666 |
|
| 2011 |
Wicklund L, Marutle A, Hertwig L, Hovatta O, Nordberg A, Darreh-Shori T. The influence of beta-amyloid 1-42 on inflammatory processes and regenerative mechanisms in Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1209 |
0.376 |
|
| 2011 |
Marutle A, Bergfors A, Ni R, Nennesmo I, Gillberg P, Nordberg A. P2-329: Laminar distributions of fibrillar β-amyloid and activated astrocytes in Alzheimer's disease autopsy brain: A quantitative autoradiography study Alzheimer's & Dementia. 7: S414-S415. DOI: 10.1016/J.Jalz.2011.05.1205 |
0.704 |
|
| 2011 |
Darreh-Shori T, Bälter M, Siawesh M, Nordberg A. Impact of Butyrylcholinesterase K genotype on glial and proinflammatory markers in CSF of patients with Alzheimer's disease. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1181 |
0.371 |
|
| 2011 |
Bao F, Lacor P, Klein W, Marutle A, Nordberg A. P2-213: Different distribution of soluble beta-amyloid assemblies in the Tg2576 mouse brain and Alzheimer disease autopsy brain Alzheimer's & Dementia. 7: S380-S381. DOI: 10.1016/J.Jalz.2011.05.1096 |
0.388 |
|
| 2010 |
Wicklund L, Leão RN, Strömberg AM, Mousavi M, Hovatta O, Nordberg A, Marutle A. Β-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. Plos One. 5: e15600. PMID 21179413 DOI: 10.1371/Journal.Pone.0015600 |
0.391 |
|
| 2010 |
Kadir A, Nordberg A. Target-specific PET probes for neurodegenerative disorders related to dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1418-30. PMID 20810758 DOI: 10.2967/Jnumed.110.077164 |
0.475 |
|
| 2010 |
Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, Muñoz-Torrero D, Badia A, Giménez-Llort L, Nordberg A. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neuro-Degenerative Diseases. 7: 379-88. PMID 20689242 DOI: 10.1159/000287954 |
0.441 |
|
| 2010 |
Degerman Gunnarsson M, Lindau M, Wall A, Blennow K, Darreh-Shori T, Basu S, Nordberg A, Larsson A, Lannfelt L, Basun H, Kilander L. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dementia and Geriatric Cognitive Disorders. 29: 204-12. PMID 20332638 DOI: 10.1159/000281832 |
0.495 |
|
| 2010 |
Forsberg A, Almkvist O, Engler H, Wall A, Långström B, Nordberg A. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters. Current Alzheimer Research. 7: 56-66. PMID 20205671 DOI: 10.2174/156720510790274446 |
0.67 |
|
| 2010 |
Nordberg A. Amyloid imaging in early detection of Alzheimer's disease. Neuro-Degenerative Diseases. 7: 136-8. PMID 20197692 DOI: 10.1159/000289223 |
0.528 |
|
| 2010 |
Nordberg A, Rinne JO, Kadir A, Långström B. The use of PET in Alzheimer disease. Nature Reviews. Neurology. 6: 78-87. PMID 20139997 DOI: 10.1038/Nrneurol.2009.217 |
0.538 |
|
| 2010 |
Lilja A, Porras O, Storelli E, Nordberg A, Marutle A. P.1.022 Amyloid aggregation is critical for the interaction with neuronal nicotinic acetylcholine receptors (nAChRs) – implications for neuroprotection in Alzheimer's disease European Neuropsychopharmacology. 20: S19-S20. DOI: 10.1016/S0924-977X(10)70024-9 |
0.391 |
|
| 2010 |
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. P4-089: Investigating Astrocytes With C11-deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's - A Multi-tracer Positron Emission Tomography Paradigm Alzheimer's & Dementia. 6: e48-e49. DOI: 10.1016/J.Jalz.2010.08.149 |
0.804 |
|
| 2010 |
Schöll M, Almkvist O, Wall A, Engler H, Kinhult-Ståhlbom A, Graff C, Nordberg A. Multitracer PET studies in kindreds with early-onset familial Alzheimer gene mutations Alzheimer's & Dementia. 6: S294. DOI: 10.1016/J.Jalz.2010.05.965 |
0.71 |
|
| 2009 |
Ferris S, Nordberg A, Soininen H, Darreh-Shori T, Lane R. Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment. Pharmacogenetics and Genomics. 19: 635-46. PMID 19617863 DOI: 10.1097/Fpc.0B013E32832F8C17 |
0.419 |
|
| 2009 |
Nordberg A. Molecular imaging markers in clinical trials in Alzheimer s disease. The Journal of Nutrition, Health & Aging. 13: 346-7. PMID 19300875 DOI: 10.1007/S12603-009-0038-5 |
0.378 |
|
| 2009 |
Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients. Current Alzheimer Research. 6: 4-14. PMID 19199870 DOI: 10.2174/156720509787313961 |
0.415 |
|
| 2009 |
Nordberg A. The future: new methods of imaging exploration in Alzheimer's disease. Frontiers of Neurology and Neuroscience. 24: 47-53. PMID 19182462 DOI: 10.1159/000197883 |
0.509 |
|
| 2009 |
Svedberg MM, Hall H, Hellström-Lindahl E, Estrada S, Guan Z, Nordberg A, Långström B. [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients. Neurochemistry International. 54: 347-57. PMID 19162107 DOI: 10.1016/J.Neuint.2008.12.016 |
0.437 |
|
| 2009 |
Nordberg A, Forsberg A, Kadir A, Almkvist O, Engler H, Långström B. S.4.02 Time course in evolution of brain amyloid and its relation to cognitive impairment in Alzheimer's disease European Neuropsychopharmacology. 19: S125-S126. DOI: 10.1016/S0924-977X(09)70133-6 |
0.627 |
|
| 2009 |
Kadir A, Zetterberg H, Andreasen N, Almkvist O, Wall A, Forsberg A, Blennow K, Långström B, Nordberg A. IC-O2-03: Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers Alzheimer's & Dementia. 5: P6-P6. DOI: 10.1016/J.Jalz.2009.05.019 |
0.58 |
|
| 2009 |
Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006 |
0.761 |
|
| 2009 |
Darreh-Shori T, Modiri N, Nordberg A. ApoE and amyloid beta deflate the cholinergic neurotransmission by boosting the activity and stability of cholinesterases in the brain Alzheimers & Dementia. 5: 305. DOI: 10.1016/J.Jalz.2009.04.463 |
0.329 |
|
| 2009 |
Lithner CU, Hernandez CM, Nordberg A, Sweatt JD. P2-146: Epigenetic changes related to beta-amyloid-implications for Alzheimer's disease Alzheimer's & Dementia. 5: P304-P304. DOI: 10.1016/J.Jalz.2009.04.457 |
0.389 |
|
| 2008 |
Blomquist G, Engler H, Nordberg A, Ringheim A, Wall A, Forsberg A, Estrada S, Frändberg P, Antoni G, Långström B. Unidirectional Influx and Net Accumulation of PIB. The Open Neuroimaging Journal. 2: 114-25. PMID 19526073 DOI: 10.2174/1874440000802010114 |
0.42 |
|
| 2008 |
Nordberg A. Amyloid imaging in Alzheimer's disease. Neuropsychologia. 46: 1636-41. PMID 18468648 DOI: 10.1016/J.Neuropsychologia.2008.03.020 |
0.492 |
|
| 2008 |
Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics. 18: 289-98. PMID 18334913 DOI: 10.1097/Fpc.0B013E3282F63F29 |
0.392 |
|
| 2008 |
Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Annals of Neurology. 63: 621-31. PMID 18300284 DOI: 10.1002/Ana.21345 |
0.656 |
|
| 2008 |
Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. European Journal of Nuclear Medicine and Molecular Imaging. 35: S46-50. PMID 18188557 DOI: 10.1007/S00259-007-0700-2 |
0.477 |
|
| 2008 |
Hedberg MM, Svedberg MM, Mustafiz T, Yu WF, Mousavi M, Guan ZZ, Unger C, Nordberg A. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Neuroscience. 152: 223-33. PMID 18164554 DOI: 10.1016/J.Neuroscience.2007.11.022 |
0.327 |
|
| 2008 |
Johansson A, Savitcheva I, Forsberg A, Engler H, Långström B, Nordberg A, Askmark H. [(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results. Parkinsonism & Related Disorders. 14: 345-7. PMID 17855149 DOI: 10.1016/J.Parkreldis.2007.07.010 |
0.417 |
|
| 2008 |
Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Långström B, Kilander L. In vivo amyloid imaging with PET in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 35: 100-6. PMID 17846768 DOI: 10.1007/S00259-007-0523-1 |
0.541 |
|
| 2008 |
Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging. 29: 1456-65. PMID 17499392 DOI: 10.1016/J.Neurobiolaging.2007.03.029 |
0.682 |
|
| 2008 |
Kadir A, Darreh-Shori T, Almkvist O, Wall A, Grut M, Strandberg B, Ringheim A, B Eriksson, Blomquist G, Långström B, Nordberg A. PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiology of Aging. 29: 1204-17. PMID 17379359 DOI: 10.1016/J.Neurobiolaging.2007.02.020 |
0.612 |
|
| 2008 |
Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, Långström B, Nordberg A. Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine. Neurobiology of Aging. 29: 168-84. PMID 17196712 DOI: 10.1016/J.Neurobiolaging.2006.09.020 |
0.608 |
|
| 2008 |
Hellström-Lindahl E, Ravid R, Nordberg A. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiology of Aging. 29: 210-21. PMID 17098332 DOI: 10.1016/J.Neurobiolaging.2006.10.010 |
0.356 |
|
| 2008 |
Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. IC-P2-134: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T60-T60. DOI: 10.1016/J.Jalz.2008.05.2589 |
0.742 |
|
| 2008 |
Darreh-Shori T, Forsberg A, Andreasen N, Blennow K, Wall A, Kamil C, Långström B, Nordberg A. P3-293: Interaction between amyloid-beta peptides with butyrylcholinesterase and ApoE proteins: Mechanism of amyloid fibrils deposition in the brain of patients with Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1861 |
0.41 |
|
| 2008 |
Almkvist O, Forsberg A, Nordberg A. P3-105: Low episodic memory performance is related to high PET PIB levels in asymptomatic control subjects Alzheimer's & Dementia. 4: T549-T549. DOI: 10.1016/J.Jalz.2008.05.1670 |
0.543 |
|
| 2008 |
Schöll M, Stefanova E, Almkvist O, Axelman K, Wall A, Långström B, Lannfelt L, Viitanen M, Nordberg A. P2-075: FDG-PET studies in early-onset familial Alzheimer's disease Alzheimer's & Dementia. 4: T390-T390. DOI: 10.1016/J.Jalz.2008.05.1148 |
0.752 |
|
| 2008 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-026: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T375-T375. DOI: 10.1016/J.Jalz.2008.05.1106 |
0.621 |
|
| 2008 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. IC-P2-107: Interrelation between cortical nicotinic receptors and acetylcholinesterase activity in mild Alzheimer's patients as assessed by PET Alzheimer's & Dementia. 4: T50-T50. DOI: 10.1016/J.Jalz.2008.05.100 |
0.605 |
|
| 2007 |
Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. Proceedings of the National Academy of Sciences of the United States of America. 104: 12506-11. PMID 17640880 DOI: 10.1073/Pnas.0705346104 |
0.347 |
|
| 2007 |
Nordberg A. Amyloid imaging in Alzheimer's disease. Current Opinion in Neurology. 20: 398-402. PMID 17620873 DOI: 10.1097/Wco.0B013E3281A47744 |
0.468 |
|
| 2007 |
Famer D, Meaney S, Mousavi M, Nordberg A, Björkhem I, Crisby M. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochemical and Biophysical Research Communications. 359: 46-50. PMID 17532301 DOI: 10.1016/J.Bbrc.2007.05.033 |
0.321 |
|
| 2007 |
Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ. Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International. 50: 800-6. PMID 17412455 DOI: 10.1016/J.Neuint.2007.02.001 |
0.355 |
|
| 2007 |
Celsi F, Svedberg M, Unger C, Cotman CW, Carrì MT, Ottersen OP, Nordberg A, Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiology of Disease. 26: 342-52. PMID 17344052 DOI: 10.1016/J.Nbd.2006.12.022 |
0.385 |
|
| 2007 |
Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. Psychopharmacology. 191: 1005-14. PMID 17310387 DOI: 10.1007/S00213-007-0725-Z |
0.671 |
|
| 2007 |
Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM, Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, ... ... Nordberg A, et al. Disease mechanisms in neuroscience Neuroscientist. 13: 99. DOI: 10.1177/10738584070130020301 |
0.535 |
|
| 2007 |
Unger C, Hernandez C, Nordberg A, Sweatt J. P.1.01 Modification of histone H3 and H4 in the brain of Tg2576 transgenic mice – implications for Alzheimer's disease European Neuropsychopharmacology. 17: S2-S3. DOI: 10.1016/S0924-977X(07)00046-6 |
0.335 |
|
| 2007 |
Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Langstrom B, Nordberg A. PET imaging of amyloid depositions in MCI patients using PIB Journal of Cerebral Blood Flow and Metabolism. 27: BO03-01. |
0.336 |
|
| 2006 |
Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism. Neurobiology of Disease. 24: 326-33. PMID 16973370 DOI: 10.1016/J.Nbd.2006.07.013 |
0.638 |
|
| 2006 |
Darreh-Shori T, Meurling L, Pettersson T, Hugosson K, Hellström-Lindahl E, Andreasen N, Minthon L, Nordberg A. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 1791-801. PMID 16868793 DOI: 10.1007/S00702-006-0526-2 |
0.398 |
|
| 2006 |
Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain : a Journal of Neurology. 129: 2856-66. PMID 16854944 DOI: 10.1093/Brain/Awl178 |
0.699 |
|
| 2006 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease. Psychopharmacology. 188: 509-20. PMID 16832659 DOI: 10.1016/J.Neuroimage.2006.04.135 |
0.65 |
|
| 2006 |
Nordberg A. Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Disease and Associated Disorders. 20: S12-8. PMID 16772751 DOI: 10.1097/01.Wad.0000213804.59187.2D |
0.418 |
|
| 2006 |
Kelicen P, Nordberg A. Feedback regulation of SREBP and aromatase in A beta(25-35)-supplemented human neuroblastoma cells. Cellular and Molecular Neurobiology. 26: 225-35. PMID 16767510 DOI: 10.1007/S10571-006-9060-X |
0.351 |
|
| 2006 |
Mousavi M, Nordberg A. Expression of the alpha7, alpha4 and alpha3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and beta-amyloid. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 24: 269-73. PMID 16574369 DOI: 10.1016/J.Ijdevneu.2006.02.002 |
0.327 |
|
| 2006 |
Unger C, Svedberg MM, Yu WF, Hedberg MM, Nordberg A. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. 317: 30-6. PMID 16354790 DOI: 10.1124/Jpet.105.098566 |
0.362 |
|
| 2006 |
Stefanova E, Wall A, Almkvist O, Nilsson A, Forsberg A, Långström B, Nordberg A. Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 113: 205-18. PMID 16049637 DOI: 10.1007/S00702-005-0312-6 |
0.645 |
|
| 2006 |
Nordberg A. Emerging biology of the cholinergic system across the spectrum of Alzheimer's disease International Psychogeriatrics. 18: S3-S16. DOI: 10.1017/S1041610206003991 |
0.508 |
|
| 2006 |
HERHOLZ K, NORDBERG A, MASDEU J, GERHARD A, EBMEIER K, PAPPATA S, PERANI D, VANLAERE K, HALLDIN C, SALMON E. Imaging of Neurotransmitter Deficits: New Potential Biomarkers for Alzheimer’s Disease? Neurorx. 3: 412-412. DOI: 10.1016/J.Nurx.2006.05.026 |
0.496 |
|
| 2006 |
Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. P2-136: Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ϵ4 allele, in relation to cognitive function and cerebral glucose metabolism Alzheimer's & Dementia. 2: S273-S273. DOI: 10.1016/J.Jalz.2006.05.974 |
0.613 |
|
| 2006 |
Hedberg MM, Svedberg MM, Mustafiz T, Unger C, Nordberg A. P1-058: Different effects of L-(-)-nicotine on beta-amyloid pathology in the brain of two transgenic mouse models Alzheimer's & Dementia. 2: S111-S112. DOI: 10.1016/J.Jalz.2006.05.433 |
0.332 |
|
| 2006 |
Mousavi M, Svedberg M, Unger C, Yu W, Guan Z, Nordberg A. P1-047: Consequences of increased β-amyloid levels at different ages in the brain of transgenic mice overexpressing both human acetylcholinesterase and the APPswe mutation Alzheimer's & Dementia. 2: S108-S108. DOI: 10.1016/J.Jalz.2006.05.422 |
0.317 |
|
| 2006 |
Kadir A, Schöll M, Forsberg A, Wall A, Långström B, Nordberg A. IC-P-010: Age and ApoE interaction in Alzheimer’s disease: FDG PET study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.2215 |
0.635 |
|
| 2006 |
Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. P2-304: PET imaging of cortical 11
C-nicotine binding correlates with cognitive function of attention in Alzheimer's disease Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1144 |
0.641 |
|
| 2006 |
Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, Ringheim A, Långström B, Nordberg A. P2-303: Amyloid depositions in MCI-patients studied with PIB-PET Alzheimer's & Dementia. 2: S329-S329. DOI: 10.1016/J.Jalz.2006.05.1143 |
0.634 |
|
| 2006 |
Scholl M, Kadir A, Forsberg A, Wall A, Langstrom B, Nordberg A. P2-267: Regional cerebral glucose metabolism (CMRGLC) as measured BY 18FDG-PET and Abeta1-42 and tau levels in CSF of Alzheimer patients who are carriers or non-carriers of the APOE ε4 allele genotype Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1106 |
0.67 |
|
| 2005 |
Unger C, Hedberg MM, Mustafiz T, Svedberg MM, Nordberg A. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels. Molecular and Cellular Neurosciences. 30: 218-27. PMID 16107318 DOI: 10.1016/J.Mcn.2005.07.012 |
0.327 |
|
| 2005 |
Xiu J, Nordberg A, Zhang JT, Guan ZZ. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochemistry International. 47: 281-90. PMID 15955596 DOI: 10.1016/J.Neuint.2005.04.023 |
0.306 |
|
| 2005 |
Yu WF, Guan ZZ, Bogdanovic N, Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques. Experimental Neurology. 192: 215-25. PMID 15698636 DOI: 10.1016/J.Expneurol.2004.12.015 |
0.379 |
|
| 2005 |
Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends in Pharmacological Sciences. 26: 104-11. PMID 15681028 DOI: 10.1016/J.Tips.2004.12.010 |
0.435 |
|
| 2005 |
Blomquist G, Hinz R, Engler H, Nordberg A, Långström B. Different patterns of PIB uptake in AD patients Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0666 |
0.381 |
|
| 2005 |
Forsberg A, Engler H, Larsson E, Blomquist G, Wall A, Långström B, Nordberg A. Follow-up study of amyloid deposition and glucose metabolism in patients with Alzheimer's disease Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0415 |
0.427 |
|
| 2004 |
Nordberg A. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo? European Journal of Nuclear Medicine and Molecular Imaging. 31: 1540-3. PMID 15372212 DOI: 10.1007/s00259-004-1677-8 |
0.358 |
|
| 2004 |
Nordberg A. PET imaging of amyloid in Alzheimer's disease. The Lancet. Neurology. 3: 519-27. PMID 15324720 DOI: 10.1016/S1474-4422(04)00853-1 |
0.519 |
|
| 2004 |
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine. 256: 240-6. PMID 15324367 DOI: 10.1111/J.1365-2796.2004.01380.X |
0.537 |
|
| 2004 |
Almkvist O, Darreh-Shori T, Stefanova E, Spiegel R, Nordberg A. Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 253-61. PMID 15061827 DOI: 10.1046/J.1468-1331.2003.00757.X |
0.615 |
|
| 2004 |
Darreh-Shori T, Hellström-Lindahl E, Flores-Flores C, Guan ZZ, Soreq H, Nordberg A. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients. Journal of Neurochemistry. 88: 1102-13. PMID 15009666 DOI: 10.1046/J.1471-4159.2003.02230.X |
0.399 |
|
| 2004 |
Hellström-Lindahl E, Mousavi M, Ravid R, Nordberg A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiology of Disease. 15: 351-60. PMID 15006705 DOI: 10.1016/J.Nbd.2003.11.024 |
0.404 |
|
| 2004 |
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals of Neurology. 55: 306-19. PMID 14991808 DOI: 10.1002/Ana.20009 |
0.47 |
|
| 2004 |
Nordberg A. Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. Progress in Brain Research. 145: 301-10. PMID 14650924 DOI: 10.1016/S0079-6123(03)45021-8 |
0.49 |
|
| 2004 |
Yu W, Guan Z, Bogadanovic N, Nordberg A. P3-163 Higher expression of alpha7 nicotinic receptor on astrocytes in Alzheimer patients with Swedish APP 670/671mutation compared to sporadic Alzheimer's disease Neurobiology of Aging. 25: S402. DOI: 10.1016/S0197-4580(04)81315-0 |
0.406 |
|
| 2004 |
Stefanova E, Axelman K, Almkvist O, Wall A, Lannfelt L, Lngström B, Nordberg A. P3-083 FDG PET reveals decreased cerebral glucose metabolism in presymptomatic carriers of the HIS163TYR mutation in the presenilin-1 gene at risk for developing familial Alzheimer's disease Neurobiology of Aging. 25: S377. DOI: 10.1016/S0197-4580(04)81235-1 |
0.615 |
|
| 2004 |
Nordberg A, Engler H, Blomqvist G, Almkvist O, Ausén B, Wall A, Lngström B. O3-03-08 Imaging of amyloid in brain in vivo in MCI and AD patients Neurobiology of Aging. 25: S59. DOI: 10.1016/S0197-4580(04)80198-2 |
0.611 |
|
| 2003 |
Klunk WE, Engler H, Nordberg A, Bacskai BJ, Wang Y, Price JC, Bergström M, Hyman BT, Långström B, Mathis CA. Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography. Neuroimaging Clinics of North America. 13: 781-9, ix. PMID 15024961 DOI: 10.1016/S1052-5149(03)00092-3 |
0.499 |
|
| 2003 |
Nordberg A. Toward an early diagnosis and treatment of Alzheimer's disease. International Psychogeriatrics / Ipa. 15: 223-37. PMID 14756159 DOI: 10.1017/S1041610203009499 |
0.484 |
|
| 2003 |
Mousavi M, Hellström-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A. Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease. Neuroscience. 122: 515-20. PMID 14614915 DOI: 10.1016/S0306-4522(03)00460-3 |
0.314 |
|
| 2003 |
Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurologica Scandinavica. Supplementum. 179: 52-76. PMID 12603252 DOI: 10.1034/J.1600-0404.107.S179.10.X |
0.405 |
|
| 2003 |
Stefanova E, Blennow K, Almkvist O, Hellström-Lindahl E, Nordberg A. Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients. Neuroscience Letters. 338: 159-63. PMID 12566177 DOI: 10.1016/S0304-3940(02)01384-8 |
0.642 |
|
| 2003 |
Yu WF, Nordberg A, Ravid R, Guan ZZ. Correlation of oxidative stress and the loss of the nicotinic receptor alpha 4 subunit in the temporal cortex of patients with Alzheimer's disease. Neuroscience Letters. 338: 13-6. PMID 12565129 DOI: 10.1016/S0304-3940(02)01361-7 |
0.398 |
|
| 2002 |
Long YG, Wang YN, Chen J, Jiang SF, Nordberg A, Guan ZZ. Chronic fluoride toxicity decreases the number of nicotinic acetylcholine receptors in rat brain. Neurotoxicology and Teratology. 24: 751-7. PMID 12460657 DOI: 10.1016/S0892-0362(02)00273-8 |
0.304 |
|
| 2002 |
Darreh-Shori T, Almkvist O, Guan ZZ, Garlind A, Strandberg B, Svensson AL, Soreq H, Hellström-Lindahl E, Nordberg A. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59: 563-72. PMID 12196650 DOI: 10.1212/Wnl.59.4.563 |
0.561 |
|
| 2002 |
Marutle A, Unger C, Hellström-Lindahl E, Wang J, Puoliväli J, Tanila H, Nordberg A, Zhang X. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Neuroscience Letters. 328: 269-72. PMID 12147323 DOI: 10.1016/S0304-3940(02)00546-3 |
0.329 |
|
| 2002 |
Bednar I, Paterson D, Marutle A, Pham TM, Svedberg M, Hellström-Lindahl E, Mousavi M, Court J, Morris C, Perry E, Mohammed A, Zhang X, Nordberg A. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Molecular and Cellular Neurosciences. 20: 354-65. PMID 12093166 DOI: 10.1006/Mcne.2002.1112 |
0.33 |
|
| 2002 |
Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). Journal of Neurochemistry. 81: 655-8. PMID 12065674 DOI: 10.1046/J.1471-4159.2002.00874.X |
0.409 |
|
| 2002 |
Hartvig P, Nordberg A, Torstenson R, Sjöberg P, Fasth KJ, Långström B. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Dementia and Geriatric Cognitive Disorders. 13: 199-204. PMID 12006729 DOI: 10.1159/000057697 |
0.306 |
|
| 2001 |
Guan ZZ, Miao H, Tian JY, Unger C, Nordberg A, Zhang X. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 1417-33. PMID 11810405 DOI: 10.1007/S007020100017 |
0.418 |
|
| 2001 |
Arnáiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12: 851-5. PMID 11277595 DOI: 10.1097/00001756-200103260-00045 |
0.62 |
|
| 2001 |
Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biological Psychiatry. 49: 200-10. PMID 11230871 DOI: 10.1016/S0006-3223(00)01125-2 |
0.428 |
|
| 2001 |
Almkvist O, Jelic V, Amberla K, Hellström-Lindahl E, Meurling L, Nordberg A. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients. Dementia and Geriatric Cognitive Disorders. 12: 22-32. PMID 11125238 DOI: 10.1159/000051232 |
0.574 |
|
| 2000 |
Nordberg A. Neuroprotection in Alzheimer's disease - new strategies for treatment. Neurotoxicity Research. 2: 157-65. PMID 16787838 DOI: 10.1007/Bf03033791 |
0.389 |
|
| 2000 |
Sihver W, Långström B, Nordberg A. Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain. Acta Neurologica Scandinavica. Supplementum. 176: 27-33. PMID 11261802 DOI: 10.1034/J.1600-0404.2000.00304.X |
0.42 |
|
| 2000 |
Algotsson A, Nordberg A, Winblad B. Apolipoprotein E varepsilon4 allele has an impact on vascular reactivity in Alzheimer's disease. Archives of Gerontology and Geriatrics. 31: 221-231. PMID 11154777 DOI: 10.1016/S0167-4943(00)00082-0 |
0.365 |
|
| 2000 |
Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, Maurer K, Winblad B, Nordberg A. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 111: 1817-24. PMID 11018498 DOI: 10.1016/S1388-2457(00)00427-2 |
0.398 |
|
| 2000 |
Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED. Development of ligands for in vivo imaging of cerebral nicotinic receptors. Behavioural Brain Research. 113: 143-57. PMID 10942041 DOI: 10.1016/S0166-4328(00)00209-6 |
0.343 |
|
| 2000 |
Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiology of Aging. 21: 533-40. PMID 10924766 DOI: 10.1016/S0197-4580(00)00153-6 |
0.594 |
|
| 2000 |
Jelic V, Nordberg A. Early diagnosis of Alzheimer disease with positron emission tomography. Alzheimer Disease and Associated Disorders. 14: S109-13. PMID 10850738 DOI: 10.1097/00002093-200000001-00016 |
0.461 |
|
| 2000 |
Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Progress in Neurobiology. 61: 75-111. PMID 10759066 DOI: 10.1016/S0301-0082(99)00045-3 |
0.337 |
|
| 2000 |
Hellström-Lindahl E, Moore H, Nordberg A. Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists. Journal of Neurochemistry. 74: 777-84. PMID 10646530 DOI: 10.1046/J.1471-4159.2000.740777.X |
0.349 |
|
| 2000 |
Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. Journal of Neurochemistry. 74: 237-43. PMID 10617125 DOI: 10.1046/J.1471-4159.2000.0740237.X |
0.343 |
|
| 2000 |
Darreh-Shori T, Svensson A, Nordberg A. Long term rivastigmine treatment produces persistent inhibition of acetyl- and butyrylcholinesterase activity in CSF of Alzheimer's patients Neurobiology of Aging. 21: 243. DOI: 10.1016/S0197-4580(00)83431-4 |
0.333 |
|
| 2000 |
Nordberg A. Brain functional imaging in early and preclinical Alzheimer's disease Neurobiology of Aging. 21: 74. DOI: 10.1016/S0197-4580(00)82554-3 |
0.418 |
|
| 2000 |
Guan Z, Zhang X, Nordberg A. A possible mechanism for nicotinic acetylcholine receptor deficit in Alzheimer brain—lipid peroxidation and distructure of biological cellular mambrane Neurobiology of Aging. 21: 188. DOI: 10.1016/S0197-4580(00)82187-9 |
0.323 |
|
| 1999 |
Nordberg A. PET studies and cholinergic therapy in Alzheimer's disease. Revue Neurologique. 155: S53-63. PMID 10637939 |
0.354 |
|
| 1999 |
Sihver W, Fasth KJ, Ogren M, Lundqvist H, Bergström M, Watanabe Y, Långström B, Nordberg A. In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys. Nuclear Medicine and Biology. 26: 633-40. PMID 10587101 DOI: 10.1016/S0969-8051(99)00034-7 |
0.33 |
|
| 1999 |
Sihver W, Gillberg PG, Svensson AL, Nordberg A. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease. Neuroscience. 94: 685-96. PMID 10579560 DOI: 10.1016/S0306-4522(99)00295-X |
0.308 |
|
| 1999 |
Wahlund LO, Basun H, Almkvist O, Julin P, Axelman K, Shigeta M, Jelic V, Nordberg A, Lannfelt L. A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation. Dementia and Geriatric Cognitive Disorders. 10: 526-33. PMID 10559570 DOI: 10.1159/000017200 |
0.644 |
|
| 1999 |
Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566 DOI: 10.1159/000017196 |
0.639 |
|
| 1999 |
Sihver W, Fasth KJ, Horti AG, Koren AO, Bergström M, Lu L, Hagberg G, Lundqvist H, Dannals RF, London ED, Nordberg A, Långström B. Synthesis and characterization of binding of 5-[76Br]bromo-3-[[2(S)-azetidinyl]methoxy]pyridine, a novel nicotinic acetylcholine receptor ligand, in rat brain. Journal of Neurochemistry. 73: 1264-72. PMID 10461920 DOI: 10.1046/J.1471-4159.1999.0731264.X |
0.325 |
|
| 1999 |
Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 52: 1861-70. PMID 10371535 DOI: 10.1212/Wnl.52.9.1861 |
0.593 |
|
| 1999 |
Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Brain Research. Molecular Brain Research. 66: 94-103. PMID 10095081 DOI: 10.1016/S0169-328X(99)00030-3 |
0.365 |
|
| 1999 |
Marutle A, Warpman U, Bogdanovic N, Lannfelt L, Nordberg A. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. Journal of Neurochemistry. 72: 1161-9. PMID 10037489 DOI: 10.1046/J.1471-4159.2000.0721161.X |
0.384 |
|
| 1999 |
Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Contents Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 553-555. DOI: 10.1159/000017205 |
0.444 |
|
| 1999 |
Ji Y, Urakami K, Adachi Y, Nakashima K, Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, ... ... Nordberg A, et al. Subject Index Vol. 10, 1999 Dementia and Geriatric Cognitive Disorders. 10: 551-552. DOI: 10.1159/000017204 |
0.459 |
|
| 1998 |
Bednar I, Zhang X, Dastranj-Sedghi R, Nordberg A. Differential changes of nicotinic receptors in the rat brain following ibotenic acid and 192-IgG saporin lesions of the nucleus basalis magnocellularis. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 16: 661-8. PMID 10198814 DOI: 10.1016/S0736-5748(98)00076-8 |
0.302 |
|
| 1998 |
Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Safety. 19: 465-80. PMID 9880090 DOI: 10.2165/00002018-199819060-00004 |
0.338 |
|
| 1998 |
Jelic V, Dierks T, Amberla K, Almkvist O, Winblad B, Nordberg A. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease. Neuroscience Letters. 254: 85-8. PMID 9779926 DOI: 10.1016/S0304-3940(98)00669-7 |
0.579 |
|
| 1998 |
Lundqvist H, Nordberg A, Hartvig P, Långström B. (S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain. Alzheimer Disease and Associated Disorders. 12: 238-46. PMID 9772029 DOI: 10.1097/00002093-199809000-00018 |
0.387 |
|
| 1998 |
Nordberg A, Amberla K, Shigeta M, Lundqvist H, Viitanen M, Hellström-Lindahl E, Johansson M, Andersson J, Hartvig P, Lilja A, Långström B, Winblad B. Long-term tacrine treatment in three mild Alzheimer patients: effects on nicotinic receptors, cerebral blood flow, glucose metabolism, EEG, and cognitive abilities. Alzheimer Disease and Associated Disorders. 12: 228-37. PMID 9772028 DOI: 10.1097/00002093-199809000-00017 |
0.372 |
|
| 1998 |
Sihver W, Fasth KJ, Ogren M, Bivehed H, Bergström M, Nordberg A, Watanabe Y, Långström B. In vitro evaluation of 11C-labeled (S)-nicotine, (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (R,S)-1-methyl-2-(3-pyridyl)azetidine as nicotinic receptor ligands for positron emission tomography studies. Journal of Neurochemistry. 71: 1750-60. PMID 9751211 DOI: 10.1046/J.1471-4159.1998.71041750.X |
0.311 |
|
| 1998 |
Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9: 246-57. PMID 9701676 DOI: 10.1159/000017069 |
0.333 |
|
| 1997 |
Bäckman L, Almkvist O, Andersson J, Nordberg A, Winblad B, Reineck R, Långström B. Brain activation in young and older adults during implicit and explicit retrieval. Journal of Cognitive Neuroscience. 9: 378-91. PMID 23965013 DOI: 10.1162/Jocn.1997.9.3.378 |
0.499 |
|
| 1997 |
Hartvig P, Torstenson R, Bjurling P, Fasth KJ, Längström B, Nordberg A. Regional brain distribution and binding of the muscarinic receptor agonist CI-979 studied by positron emission tomography in the monkey. Dementia and Geriatric Cognitive Disorders. 8: 259-66. PMID 9298626 DOI: 10.1159/000106642 |
0.303 |
|
| 1997 |
Svensson AL, Warpman U, Hellström-Lindahl E, Bogdanovic N, Lannfelt L, Nordberg A. Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes. Neuroscience Letters. 232: 37-40. PMID 9292886 DOI: 10.1016/S0304-3940(97)00573-9 |
0.422 |
|
| 1997 |
Lundqvist H, Långström B, Nordberg A. Use of carbon-11 nicotine in PET studies. European Journal of Nuclear Medicine. 24: 825-6. PMID 9289404 DOI: 10.1007/Bf00879673 |
0.318 |
|
| 1997 |
Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. Journal of Neurology, Neurosurgery, and Psychiatry. 63: 59-65. PMID 9221969 DOI: 10.1136/Jnnp.63.1.59 |
0.387 |
|
| 1997 |
Corder EH, Jelic V, Basun H, Lannfelt L, Valind S, Winblad B, Nordberg A. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. Archives of Neurology. 54: 273-7. PMID 9074396 DOI: 10.1001/Archneur.1997.00550150035013 |
0.438 |
|
| 1997 |
Nordberg A, Lundqvist H, Hartvig P, Andersson J, Johansson M, HellstrÅm-Lindahi E, LÃ¥ngström B. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dementia and Geriatric Cognitive Disorders. 8: 78-84. PMID 9065319 DOI: 10.1159/000106611 |
0.414 |
|
| 1996 |
Algotsson A, Nordberg A, Lannfelt L, Almkvist O, Winblad B. Apolipoprotein E epsilon4 allele, skin vessel reactivity and vascular risk factors in Alzheimer's disease. Archives of Gerontology and Geriatrics. 22: 223-32. PMID 15374172 DOI: 10.1016/0167-4943(96)00695-4 |
0.572 |
|
| 1996 |
Nordberg A. Pharmacological treatment of cognitive dysfunction in dementia disorders. Acta Neurologica Scandinavica. Supplementum. 168: 87-92. PMID 8997426 DOI: 10.1111/J.1600-0404.1996.Tb00379.X |
0.375 |
|
| 1996 |
Nordberg A. Application of PET in dementia disorders. Acta Neurologica Scandinavica. Supplementum. 168: 71-6. PMID 8997424 DOI: 10.1111/J.1600-0404.1996.Tb00377.X |
0.49 |
|
| 1996 |
Johansson M, Hellström-Lindahl E, Nordberg A. Steady-state pharmacokinetics of tacrine in long-term treatment of Alzheimer patients. Dementia (Basel, Switzerland). 7: 111-7. PMID 8866685 DOI: 10.1159/000106863 |
0.301 |
|
| 1996 |
Nordberg A. Functional studies of new drugs for the treatment of Alzheimer's disease. Acta Neurologica Scandinavica. Supplementum. 165: 137-44. PMID 8741001 DOI: 10.1111/J.1600-0404.1996.Tb05884.X |
0.436 |
|
| 1996 |
Lunell E, Bergström M, Antoni G, Långström B, Nordberg A. Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography. Clinical Pharmacology and Therapeutics. 59: 593-4. PMID 8646831 DOI: 10.1016/S0009-9236(96)90188-5 |
0.307 |
|
| 1996 |
Warpman U, Marude A, Hellström-Lindahl E, Lannfelt L, Nordberg A. 721 Neuronal nicotinic receptor impairment and APOE polymorphism in Alzheimer's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80723-8 |
0.378 |
|
| 1996 |
Jönhagen M, Wahlund LO, Amberla K, Ebendal T, Meyersson B, Nordberg A, Olson L, Shigeta M, Seiger Å, Viitanen M, Winblad B. 645 Nerve Growth Factors as a Treatment of Alzheimer's Disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80647-6 |
0.325 |
|
| 1996 |
Jelic V, Almkvist O, Julin P, Wahlund L, Winblad B, Nordberg A. 367 Patterns of brain metabolism in patients with mild cognitive impairment Neurobiology of Aging. 17: S92. DOI: 10.1016/S0197-4580(96)80369-1 |
0.553 |
|
| 1995 |
Warpman U, Nordberg A. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains. Neuroreport. 6: 2419-23. PMID 8747166 DOI: 10.1097/00001756-199511270-00033 |
0.337 |
|
| 1995 |
Algotsson A, Nordberg A, Almkvist O, Winblad B. Skin vessel reactivity is impaired in Alzheimer's disease. Neurobiology of Aging. 16: 577-82. PMID 8544908 DOI: 10.1016/0197-4580(95)00077-R |
0.587 |
|
| 1995 |
James JR, Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behavior Genetics. 25: 149-59. PMID 7733856 DOI: 10.1007/Bf02196924 |
0.35 |
|
| 1995 |
Nordberg A, Lundqvist H, Hartvig P, Lilja A, Långström B. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography. Alzheimer Disease and Associated Disorders. 9: 21-7. PMID 7605618 DOI: 10.1097/00002093-199505000-00006 |
0.429 |
|
| 1994 |
Nordberg A. Human nicotinic receptors--their role in aging and dementia. Neurochemistry International. 25: 93-7. PMID 7950977 DOI: 10.1016/0197-0186(94)90059-0 |
0.395 |
|
| 1993 |
Warpman U, Alafuzoff I, Nordberg A. Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease. Neuroscience Letters. 150: 39-43. PMID 8469400 DOI: 10.1016/0304-3940(93)90103-R |
0.371 |
|
| 1993 |
Nordberg A. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET. Acta Neurologica Scandinavica. Supplementum. 149: 62-5. PMID 8128843 DOI: 10.1111/J.1600-0404.1993.Tb04259.X |
0.446 |
|
| 1993 |
Amberla K, Nordberg A, Viitanen M, Winblad B. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data. Acta Neurologica Scandinavica. Supplementum. 149: 55-7. PMID 8128841 DOI: 10.1111/J.1600-0404.1993.Tb04257.X |
0.364 |
|
| 1993 |
Seiger A, Nordberg A, von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behavioural Brain Research. 57: 255-61. PMID 8117429 DOI: 10.1016/0166-4328(93)90141-C |
0.393 |
|
| 1993 |
Nordberg A. Clinical studies in Alzheimer patients with positron emission tomography. Behavioural Brain Research. 57: 215-24. PMID 7906947 DOI: 10.1016/0166-4328(93)90138-G |
0.535 |
|
| 1993 |
Nordberg A. In vivo detection of neurotransmitter changes in Alzheimer's disease. Annals of the New York Academy of Sciences. 695: 27-33. PMID 7902055 DOI: 10.1111/J.1749-6632.1993.Tb23022.X |
0.515 |
|
| 1993 |
Nordberg A, Hartvig P, Andersson J, Lundqvist H, Vittanen M, Långström B, Winblad B. Visualization of muscarinic receptors in Alzheimer brains in vivo by positron emission tomography Life Sciences. 52: 556. DOI: 10.1016/0024-3205(93)90329-2 |
0.385 |
|
| 1993 |
Svensson A, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in normal and Alzheimer brain tissue by using selective muscarinic antagonists Life Sciences. 52: 556. DOI: 10.1016/0024-3205(93)90328-Z |
0.322 |
|
| 1992 |
Nordberg A, Alafuzoff I, Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. Journal of Neuroscience Research. 31: 103-11. PMID 1613816 DOI: 10.1002/Jnr.490310115 |
0.328 |
|
| 1992 |
Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M, Hellström-Lindahl E, Bjurling P. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiology of Aging. 13: 747-58. PMID 1491741 DOI: 10.1016/0197-4580(92)90099-J |
0.465 |
|
| 1992 |
Svensson AL, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Research. 596: 142-8. PMID 1467980 DOI: 10.1016/0006-8993(92)91541-L |
0.322 |
|
| 1992 |
Svensson A, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer brains Neurobiology of Aging. 13: S132. DOI: 10.1016/0197-4580(92)90649-I |
0.359 |
|
| 1992 |
Warpman U, Alafuzoff I, Nordberg A. Defect coupling of muscarinic receptors to GTP-proteins in Alzheimer brains Neurobiology of Aging. 13: S61. DOI: 10.1016/0197-4580(92)90368-8 |
0.317 |
|
| 1991 |
Nordberg A, Hartvig P, Lilja A, Viitanen M, Amberla K, Lundqvist H, Andersson J, Nybäck H, Ulin J, Anderson Y. Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography. Acta Radiologica. Supplementum. 376: 165-6. PMID 1666767 |
0.306 |
|
| 1990 |
Nordberg A, Adem A, Nilsson-Håkansson L, Bucht G, Hartvig P, Alafuzoff I, Viitanen M, Långström B, Winblad B. New approaches to clinical and postmortem investigations of cholinergic mechanisms. Progress in Brain Research. 84: 313-20. PMID 2267305 DOI: 10.1016/S0079-6123(08)60915-2 |
0.333 |
|
| 1990 |
Nordberg A. Pharmacological modulation of transmitter activity in Alzheimer brains--an experimental model. Acta Neurologica Scandinavica. Supplementum. 129: 17-20. PMID 1977274 DOI: 10.1111/J.1600-0404.1990.Tb02597.X |
0.336 |
|
| 1990 |
Sakurada T, Alufuzoff I, Winblad B, Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Research. 521: 329-32. PMID 1698512 DOI: 10.1016/0006-8993(90)91561-T |
0.449 |
|
| 1989 |
Nordberg A, Nilsson-HÃ¥kansson L, Adem A, Hardy J, Alafuzoff I, Lai Z, Herrera-Marschitz M, Winblad B. The role of nicotinic receptors in the pathophysiology of Alzheimer's disease. Progress in Brain Research. 79: 353-62. PMID 2685906 DOI: 10.1016/S0079-6123(08)62495-4 |
0.339 |
|
| 1988 |
Nordberg A, Adem A, Hardy J, Winblad B. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains Neuroscience Letters. 86: 317-321. PMID 3380323 DOI: 10.1016/0304-3940(88)90503-4 |
0.363 |
|
| 1987 |
Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? Journal of Neural Transmission. 70: 357-368. PMID 3681290 DOI: 10.1007/Bf01253610 |
0.311 |
|
| 1987 |
Nordberg A, Nyberg P, Adolfsson R, Winblad B. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile. Journal of Neural Transmission. 69: 19-32. PMID 3585318 DOI: 10.1007/Bf01244094 |
0.411 |
|
| 1986 |
Adem A, Nordberg A, Bucht G, Winblad B. Extraneural cholinergic markers in Alzheimer's and Parkinson's disease Progress in Neuropsychopharmacology and Biological Psychiatry. 10: 247-257. PMID 3797683 DOI: 10.1016/0278-5846(86)90005-9 |
0.419 |
|
| 1986 |
Nordberg A, Alafuzoff I, Winblad B. Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type. Neuroscience Letters. 70: 160-4. PMID 3774212 DOI: 10.1016/0304-3940(86)90456-8 |
0.412 |
|
| 1985 |
Nyberg P, Adolfsson R, Hardy JA, Nordberg A, Wester P, Winblad B. Catecholamine topochemistry in human basal ganglia. Comparison between normal and Alzheimer brains. Brain Research. 333: 139-42. PMID 3995281 DOI: 10.1016/0006-8993(85)90133-7 |
0.358 |
|
| 1983 |
Gottfries C, Adolfsson R, Aquilonius S, Carlsson A, Eckernas S, Nordberg A, Oreland L, Svennerholm L, Wiberg Å, Winblad B. Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiology of Aging. 4: 261-271. PMID 6200784 DOI: 10.1016/0197-4580(83)90002-7 |
0.443 |
|
| 1983 |
Nordberg A, Larsson C, Adolfsson R, Alafuzoff I, Winblad B. Muscarinic receptor compensation in hippocampus of Alzheimer patients. Journal of Neural Transmission. 56: 13-9. PMID 6133910 DOI: 10.1007/Bf01243370 |
0.336 |
|
| Show low-probability matches. |
